Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep279 | General Endocrinology | ECE2020

Myasthenia gravis during anti PD-1 therapy

Jankowska Katarzyna , Zgliczynski Wojciech

A 66-year-old patient was diagnosed with lung cancer. In the interview, smoking for 40 years, about 20 cigarettes/day. Due to the intensifying cough, an x-ray of the chest was performed, a large tumor (12 cm) of the mediastinum and the right cavity was found. In the histopathological examination squamous cell carcinoma. Stage T4 N2 M0. Due to tumor inoperability, the patient was qualified for sequential chemo-radiotherapy. He received 3 cycles of chemotherapy (navelbin and cis...

ea0016p260 | Diabetes and cardiovascular diseases | ECE2008

The high prevalence of testosterone deficiency syndrome and erectile dysfunctions in the aging men with diabetes mellitus type 2

Rabijewski Michal , Zgliczynski Wojciech

Objective: The aim of the study was to determine the prevalence of subclinical late-onset hypogonadism (SLOH) and erectile dysfunctions in the elderly men with diabetes type 2.Material and methods: We investigated 51 men mean aged 68.3 years with diabetes type 2 according ADA recommendations. Androgens concentrations, BMI, HbA1C were measured. All of men were treated with oral antidiabetic drugs or insulin. LOH was expected on the basis of low testostero...

ea0016p261 | Diabetes and cardiovascular diseases | ECE2008

The influence of testosteone replacement therapy on erectile dysfunctions in aging men with testosterone deficiency and diabetes mellitus type 2

Rabijewski Michal , Zgliczynski Wojciech

Objective: The role of testosterone in the anatomy and physiology of erection is becoming clear. Erectile dysfunctions (ED) are very common observed in men with diabetes mellitus type 2 (DM2). The aim of the study was to determine the efficacy of testosterone adminisartions in elderly men with ED and DM2.Material and methods: We investigated 41 men mean aged 65.4 years with late onset hypogonadism according Polish Endocrine Society recommendations and DM...

ea0014p601 | (1) | ECE2007

Glucose resistance in acromegaly is reversible during somatostatin analogues treatment

Zdunowski Piotr , Zgliczynski Wojciech

Background: Insulin resistance leading to glucose intolerance and even diabetes mellitus is common in acromegaly and is partially caused by pathological high concentrations of growth hormone (GH) and somatomedin C (IGF-1). On the other hand, somatostatin analogues, common treatment option, can cause inhibition of insulin secretion and glucose tolerance disturbances.Aim: Of the study was to determine impact of prolonged somatostatin analogues administrati...

ea0070ep404 | Reproductive and Developmental Endocrinology | ECE2020

DHEA in infertility – can you reverse the flow of time?

Jankowska Katarzyna , Maksym Radoslaw , Zgliczynski Wojciech

We study the impact of the dehydroepiandrosterone (DHEA) by the women with diminished ovarian reserve and very low DHEA-S in the blood.Patients: We present a description of 7 patients with diminished ovarian reserve (DOR). Patients reported because of problems with getting pregnant. Infertility lasted for several years. The patients disagreed on IVF for ethical and religious reasons. All of the presented patients were diagnosed with diminished ovarian re...

ea0032p925 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

The influence of octreotide-LAR treatment on glucose homeostasis in acromegaly

Stelmachowska-Banas Maria , Zdunowski Piotr , Zgliczynski Wojciech

Introduction: Generously supported by IPSEN)-->Impaired glucose tolerance and insulin resistance are frequently associated with acromegaly. The aim of this study was to assess the effect of octreotide-LAR treatment on glucose homeostasis in acromegalic patients.Patients and methods: In this prospective study 16 naïve acromegalic patients were studied before and after 3-month therapy of octreotide-LAR (20 m...

ea0016p324 | Endocrine tumours | ECE2008

Abnormalities in glucose tolerance in acromegalic patients

Stelmachowska-Banas Maria , Zdunowski Piotr , Zgliczynski Wojciech

Background: Acromegaly is characterized by disabling symptoms and relevant comorbidities. Insulin resistance, leading to glucose intolerance is one of the most important contributory factor to the cardiovascular mortality in acromegaly.Aim: To assess the impairments of glucose homeostasis in acromegalic patients and find association between activity of the disease and the severity of glucose intolerance.Patients and methods: In thi...

ea0014p82 | (1) | ECE2007

Dehydroepiandrosterone therapy in men with verified coronary heart disease: the effects on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA)

Rabijewski Michal , Papierska Lucyna , Zgliczynski Wojciech

Objectives: The aim of this study was to analyze the influence of DHEA therapy on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) plasma concentrations in men with decreased serum DHEAS levels and angiographically verified coronary heart disease (CHD).Material and methods: The study included thirty men aged 41–60 years (mean age 52±0.90 yr) with serum DHEAS concentration <2000 μg/l, who were...

ea0014p258 | (1) | ECE2007

The relationship between plasma androgens (testosterone and dehydroepiandrosterone sulfate), insulin resistance and visceral obesity in elderly men

Rabijewski Michal , Papierska Lucyna , Zgliczynski Wojciech

Introduction: In elderly men testosterone and DHEAS deficiency is often observed, also changes of body composition and metabolic disturbances are common disorders.Objectives: The aim of this study was to analyze the association between testosterone and DHEAS deficiency and waist/hip ratio (WHR) and also levels of glucose, insulin, HOMA and FG/FI ratio in elderly men as well as analysis, whether these sex hormones influent on measured parameters separatel...

ea0014p466 | (1) | ECE2007

Insulinoma and gastrinoma in MEN 1: case report

Gietka-Czernel Margaret , Krassowski Janusz , Zgliczynski Wojciech

23-year old man was admitted to Endocrinology Department because of hypogonadism and pituitary tumor seen at CT. Diagnosis of prolactinoma was established based on high serum PRL level- 800 ng/ml and therapy with bromocriptine was instituted. On the next year a temporary loss of consciousness related to physical exertion occured. The neurological reasons were excluded and laboratory tests showed hypercalcemia, hypophosphatemia and elevated serum PTH levels. Prolactinoma and hy...